Pediatric anxiety remission up with acute treatment response

February 3, 2014
Pediatric anxiety remission up with acute treatment response

(HealthDay)—Almost half of youth with anxiety disorders are in remission at six years after randomization to interventions, with those who respond during acute treatment more likely to be in remission, according to a study published online Jan. 29 in JAMA Psychiatry.

Golda S. Ginsburg, Ph.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues conducted a naturalistic follow-up study at six academic sites in the United States and involving 288 youth (mean age, 17 years). In the Child/Adolescent Anxiety Multimodal Study (CAMS), participants were randomized to one of four interventions: , medication, combination, or pill placebo.

At a mean of six years after randomization, the researchers found that 46.5 percent of the participants were in remission (absence of all study entry ). Acute treatment responders were more likely to be in remission (odds ratio, 1.83); they also had less severe anxiety symptoms and higher functioning, irrespective of treatment arm assignment. The researchers identified several predictors of remission and functioning.

"Youths rated as responders during the acute treatment phase of CAMS were more likely to be in a mean of six years after , although the effect size was small," the authors write. "Relapse occurred in almost half (48 percent) of acute responders, suggesting the need for more intensive or continued treatment for a sizable proportion of youths with anxiety disorders."

Several authors disclosed financial ties to the pharmaceutical and publishing industries.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Alendronate reduces adjacent-level vertebral fractures

December 30, 2013

(HealthDay)—For females with osteoporosis, the rate of adjacent-level vertebral fractures is relatively low, with reduced odds with bisphosphonate therapy, according to a study published in the Dec. 1 issue of Spine.

Recommended for you

Neural efficiency hypothesis confirmed

July 27, 2015

One of the big questions intelligence researchers grapple with is just how differences in intelligence are reflected in the human brain. Researchers at ETH Zurich have succeeded in studying further details relating to suspected ...

How does color blindness affect color preferences?

July 21, 2015

(Medical Xpress)—Dichromacy is a color vision defect in which one of the three types of cone photoreceptors is missing. The condition is hereditary and sex-linked, mostly affecting males. Although researchers have explored ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.